
<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis</p>
Author(s) -
Hui Liang,
Mengzhao Wang
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s231257
Subject(s) - c met , hepatocyte growth factor , medicine , lung cancer , receptor tyrosine kinase , hepatocyte growth factor receptor , cancer research , cancer , targeted therapy , tyrosine kinase , clinical trial , epidermal growth factor receptor , oncology , receptor